Biotech Co. Preps For IPO, But May Delay Again
Venture capital-backed Zosano Pharma Inc. is the only company on the schedule to brave the public markets this week, but a delay would not come as a shock as California-based Zosano...To view the full article, register now.
Already a subscriber? Click here to view full article